Russian Pharmacy Chain Rankings in 2023

In 2023, veterinary drugs on the Russian retail market (e-com included) went up in price 26.6% from 2022. The highest price growth rates were seen in early 2023 (Fig. 1); as a result of the devaluation of the ruble and the subsequent correction of prices for imported goods on the Russian market, inflation surged in June–August 2023.

Russian Pharmaceutical Distributor Rankings in 2023

In 2023, 9.9 million medical thermometers worth 3.3 billion rubles (retail prices, VAT included) were sold on the Russian retail market (online sales included), down 12% in physical and down 15.7% in monetary terms from 2022.

In 2023, the sales of enteral nutrition on the Russian retail market (e-com included) were 4.8 billion rubles (retail prices, VAT included), or 12.4 million packages. The sales went up 12.2% in monetary terms, but went down 1.9% in physical terms, which is a clear indicator that the market was able to grow last year only because of inflation.

In 2023, 35.4 billion rubles’ worth of veterinary drugs were sold on the Russian retail market (retail prices, VAT included), up 22.5% from 2022, which is record-worthy. In physical terms, 235 million minimum dosage units (MDU) were sold, up 13%. The difference in growth rates can be easily explained by the inflation rate. Interestingly, the online market continued to actively develop—online sales went up 2.2 times in MDUs, while offline sales grew by only 5%.

In 2023, 1.38 million glucose meters and around 657.3 million glucose test strips were sold on the Russian retail market, down 0.3% and 3.5% from 2022, respectively.

In 2023, 4.9 billion rubles’ worth of nebulizers were sold on the Russian retail market (retail prices, VAT included), up only 0.5% from 2022. At the same time, the sales in physical terms went up by as much as 9.6%. Online sales alone contributed to the total growth rates, with its 40.4% in monetary terms and 67.6% in physical terms.

In 2023, Russian manufacturers produced 716.5 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), up 7.2% from 2022. In physical terms, it was 4.09 billion packages, down 2% from 2022.